Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 02, 2023

SELL
$5.9 - $6.95 $7,227 - $8,513
-1,225 Reduced 3.83%
30,754 $202,000
Q1 2023

May 02, 2023

SELL
$6.18 - $7.99 $23,885 - $30,881
-3,865 Reduced 10.78%
31,979 $217,000
Q4 2022

Jan 09, 2023

SELL
$6.87 - $10.96 $69,524 - $110,915
-10,120 Reduced 22.02%
35,844 $0
Q3 2022

Nov 04, 2022

SELL
$9.44 - $11.76 $5,484 - $6,832
-581 Reduced 1.25%
45,964 $454,000
Q2 2022

Aug 01, 2022

SELL
$9.31 - $11.84 $38,776 - $49,313
-4,165 Reduced 8.21%
46,545 $507,000
Q1 2022

May 12, 2022

BUY
$10.84 - $16.55 $12,791 - $19,529
1,180 Added 2.38%
50,710 $574,000
Q4 2021

Jan 31, 2022

BUY
$15.69 - $21.14 $777,125 - $1.05 Million
49,530 New
49,530 $777,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $290M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.